GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Progressive Care Inc (OTCPK:RXMD) » Definitions » Altman Z2-Score

Progressive Care (Progressive Care) Altman Z2-Score : -2.57 (As of Jun. 06, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Progressive Care Altman Z2-Score?

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Warning Sign:

Progressive Care has a Altman Z2-Score of -2.57, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for Progressive Care's Altman Z2-Score or its related term are showing as below:

RXMD' s Altman Z2-Score Range Over the Past 10 Years
Min: -19.54   Med: -4.05   Max: 1.53
Current: -2.57

During the past 13 years, Progressive Care's highest Altman Z2-Score was 1.53. The lowest was -19.54. And the median was -4.05.


Progressive Care Altman Z2-Score Historical Data

The historical data trend for Progressive Care's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Progressive Care Altman Z2-Score Chart

Progressive Care Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Altman Z2-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.21 -3.93 -1.83 -1.83 -2.48

Progressive Care Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.41 -2.40 1.53 -2.48 -2.57

Competitive Comparison of Progressive Care's Altman Z2-Score

For the Pharmaceutical Retailers subindustry, Progressive Care's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Progressive Care's Altman Z2-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Progressive Care's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where Progressive Care's Altman Z2-Score falls into.



Progressive Care Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

Progressive Care's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*0.2309+3.26*-0.8397+6.72*-0.4716+1.05*1.7342
=-2.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Mar. 2024:
Total Assets was $41.40 Mil.
Total Current Assets was $23.44 Mil.
Total Current Liabilities was $13.88 Mil.
Retained Earnings was $-34.76 Mil.
Pre-Tax Income was -0.372 + -13.273 + -1.375 + -4.637 = $-19.66 Mil.
Interest Expense was -0.016 + -0.016 + -0.038 + -0.065 = $-0.14 Mil.
Total Liabilities was $15.14 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(23.435 - 13.878)/41.398
=0.2309

X2=Retained Earnings/Total Assets
=-34.761/41.398
=-0.8397

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-19.657 - -0.135)/41.398
=-0.4716

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(26.257 - 0)/15.141
=1.7342

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

Progressive Care has a Altman Z2-Score of -2.57 indicating it is in Distress Zones.


Progressive Care  (OTCPK:RXMD) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


Progressive Care Altman Z2-Score Related Terms

Thank you for viewing the detailed overview of Progressive Care's Altman Z2-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Progressive Care (Progressive Care) Business Description

Traded in Other Exchanges
N/A
Address
400 Ansin Boulevard, Suite A, Hallandale Beach, FL, USA, 33009
Progressive Care Inc is a personalized healthcare services and technology company which provides prescription pharmaceutical services, risk management, and data analytics to healthcare organizations and providers. The company through its wholly-owned subsidiary Pharmco, provides prescription pharmaceuticals, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, the supply of prescription medications to long-term care facilities, and health practice risk management. It also offers certain disease testing and vaccinations. It offers services in a variety of languages, including English, Spanish, French, Creole, Portuguese, Ukrainian, and Russian.
Executives
Charles M. Fernandez director, 10 percent owner, officer: Chairman & CEO C/O FAIRHOLME CAPITAL MANAGEMENT, L.L.C., 4400 BISCAYNE BOULEVARD, 9TH FLOOR, MIAMI FL 33137
Rodney Barreto director, 10 percent owner 460 MARQUESA DRIVE, CORAL GABLES FL 33156
Pamela M Roberts officer: CHIEF OPERATING OFFICER 1540 NW 203 ST, MIAMI FL 33169
Pedro Rodriguez director 258 NE 27TH STREET, MIAMI FL 33137
Birute Norkute officer: Chief Operating Officer 2311 NE 174TH ST, MIAMI FL 33160
Alan Jay Weisberg officer: CHIEF FINANCIAL OFFICER 2500 NORTH MILITARY TRAIL, SUITE 206, BOCA RATON FL 33431
Cecile Munnik officer: CFO 400 ANSIN BLVD SUITE A, HALLANDALE BEACH FL 33009
Joseph Ziegler director 1051 HILLSBORO MILE, PH2, HILLSBORO BEACH FL 33062
Jervis Hough director 6053 BARTAM COVE, DULUTH GA 30097
Shital P Parikh director, officer: Chief Operating Officer 1111 PARK CENTER BLVD., SUITE 202, MIAMI GARDENS FL 33169
Vernon Watson officer: Chief Executive Officer 1111 PARK CENTER BLVD., SUITE 202, MIAMI GARDENS FL 33169
Armen Karapetyan 10 percent owner 17395 NORTH BAY ROAD, SUITE 102, SUNNY ISLES BEACH FL 33160
Avraham A. Friedman director, 10 percent owner, officer: Chief Executive Officer C/O PROGRESSIVE CARE INC., 901 N. MIAMI BEACH BLVD., SUITE 1, N. MIAMI BEACH FL 33162
Andy Subachan director, 10 percent owner, officer: Chief Operating Officer C/O PROGRESSIVE CARE INC., 901 N. MIAMI BEACH BLVD., SUITE 1, N. MIAMI BEACH FL 33162
Buddy Young director, 10 percent owner, officer: President, CEO, CFO, Chairman

Progressive Care (Progressive Care) Headlines